44 related articles for article (PubMed ID: 8021727)
1. Salvage camrelizumab for an intractable NK/T cell lymphoma patient with two instances of intestinal perforation: a case report and literature review.
Xia Y; Li QH; Liu T; Liu XX; Pan HX; Zhang LL; Zhu F
Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4570-4577. PubMed ID: 37259738
[TBL] [Abstract][Full Text] [Related]
2. Chronic diarrhea associated with high serum level of immunoglobulin A and diffuse infiltration of plasma cell in small intestine: A case report.
Yang J; Chen S; Chen L; Ouyang M; Li F
Medicine (Baltimore); 2017 Feb; 96(5):e6057. PubMed ID: 28151917
[TBL] [Abstract][Full Text] [Related]
3. Partial Small Bowel Obstruction and Volvulus Due to B-cell Lymphoma in a Common Variable Immunodeficiency Patient.
Adupa R; Dadigiri H; Gandhi D
Cureus; 2023 Oct; 15(10):e47269. PubMed ID: 38021662
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous free perforation of the small intestine in adults.
Freeman HJ
World J Gastroenterol; 2014 Aug; 20(29):9990-7. PubMed ID: 25110427
[TBL] [Abstract][Full Text] [Related]
5. Heavy chain disease.
Witzig TE; Wahner-Roedler DL
Curr Treat Options Oncol; 2002 Jun; 3(3):247-54. PubMed ID: 12057070
[TBL] [Abstract][Full Text] [Related]
6. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
[TBL] [Abstract][Full Text] [Related]
8. [Primary immunoproliferative small intestinal disease].
Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R
G E N; 1995; 49(3):238-42. PubMed ID: 8598264
[TBL] [Abstract][Full Text] [Related]
9. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
10. Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
Barista I; Tekuzman G; Firat D; Baltali E; Kansu E; Kars A; Ozisik Y; Ruacan S; Uzunalimoğlu B; Karaağaoğlu E
Jpn J Cancer Res; 1994 Dec; 85(12):1200-7. PubMed ID: 7531679
[TBL] [Abstract][Full Text] [Related]
11. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
Shih LY; Liaw SJ; Dunn P; Kuo TT
J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
[TBL] [Abstract][Full Text] [Related]
12. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
